4Shai RM, Reichardt JK, Chen TC. Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas[ J]. Future Oncol, 2008,4(4) :525 - 534.
5Sanson M. Editorial review: targets for glioma treatment: from bench to bedside [ J ]. Curr Opin Oncol, 2008, 20 (6) : 650 - 651.
7Sorensen AG, Batchelor TT, Wen PY, et al. Response criteria for glioma[J]. Nat Clin Pract Oncol, 2008, 5(11) :634-644.
8Brandsma D, de Bruin HG, Bromberg JE, et al. Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide [ J ]. Cancer, 2008, 113(2) :405 -410.
4Jagannathan J, Prevedello DM, Dumont AS, et al. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme [ J ]. Neurosurg Focus, 2006, 20(4) : E8.
5Brandes AA, Franceschi E, Tosoni A, et al. Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments [ J]. Clin Cancer Res, 2008, 14(4) : 957 -960.
6Cao Z, Liu LZ, Dixon DA, et al. Insulin-like growth factor-Ⅰ induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells [ J]. Cell Signal, 2007, 19 (7) : 1542-1553.
7Ran H, Yang BF, Rainov NG. Receptor tyrosine kinases as therapeutic targets in malignant glioma [ J]. Rev Recent Clin Trials, 2007, 2 ( 2 ) : 87 - 101.
8Kaul A, Overmeyer JH, Maltese WA. Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways [J]. Cell Signal, 2007, 19(5) : 1034 - 1043.
9Kieran MW. Anti-angiogenic chemotherapy in central nervous system tumors [J]. Cancer Treat Res, 2004, 117:337-349.
10Vredenburgh JJ, Desjardins A, Hemdon JE 2nd, et al. Phase Ⅱ trial of bevaeizumab and irinotecan in reeurrent malignant glioma [ J ]. Clin Cancer Res, 2007, 13(4) : 1253 - 1259.
8Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma[ J]. N Engl J Med, 2005, 352(10) :997 - 1003.
9Ino Y, Betensky RA, Zlatescu MC, et al. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis[J]. Clin Cancer Res,2001,7(4) :839 -845.
10Chen ZP, Yarosh D, Garcia Y, et al. Relationship between O^6- methylguanine-DNA methyhransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients[ J]. Can J Neurol Sci, 1999, 26(2) : 104 -109.
